Medistep HealthcareNSE:MEDISTEP +10.83%19 ROA % is 21.84% as of Mar. 2025, which is 44% above its 10-year median of 15.16. GuruFocus rates NSE:MEDISTEP with a GF Score™ of 19/100. The stock has 2 warning signs investors should review. Among 118 Medical Distribution companies, Medistep Healthcare ranks better than 98.31% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Medistep Healthcare's annualizedNet Income for the quarter that ended in Mar. 2025 was ₹41.4 Mil.
Medistep Healthcare's average Total Assets over the quarter that ended in Mar. 2025 was ₹189.7 Mil. Therefore, Medistep Healthcare's annualized ROA % for the quarter that ended in Mar. 2025 was 21.84%.
The historical rank and industry rank for Medistep Healthcare's ROA % or its related term are showing as below:
NSE:MEDISTEP'
s ROA % Range Over the Past 10 Years
Min: 2.67 Med: 15.16 Max: 22.47
Current: 21.84
During the past 4 years, Medistep Healthcare's highest ROA % was 22.47%. The lowest was 2.67%. And the median was 15.16%.
NSE:MEDISTEP's ROA % is ranked better than 98.31% of 118
companies
in the Medical Distribution industry
Industry Median: 2.215
vs NSE:MEDISTEP: 21.84
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is one times the annual (Mar. 2025) net income data. The Revenue data used here is one times the annual (Mar. 2025) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Medistep Healthcare ROA % Related Terms
Medistep Healthcare ROA % Historical Data
* Premium members only.
The historical data trend for Medistep Healthcare's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medistep Healthcare ROA % Chart
Medistep Healthcare Annual Data
Trend
Mar22
Mar23
Mar24
Mar25
ROA %
2.67
8.47
22.47
21.84
Medistep Healthcare Semi-Annual Data
Mar22
Mar23
Mar24
Mar25
ROA %
2.67
8.47
22.47
21.84
NSE:MEDISTEP vs MCK, CAH, COR: ROA % Comparison
For the Medical Distribution subindustry, Medistep Healthcare's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medistep Healthcare ROA % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Medistep Healthcare's ROA % distribution charts can be found below:
* The bar in red indicates where Medistep Healthcare's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is one times the annual (Mar. 2025) net income data.
ROA % is displayed in the 30-year financial page.
Medistep Healthcare (NSE:MEDISTEP) has a ROA % of 21.84% as of Mar. 2025. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Medistep Healthcare and its competitors. This is 44% above median its historical median of 15.16. Over the past decade, Medistep Healthcare's ROA % has ranged from 2.67 to 22.47. According to the industry distribution chart, Medistep Healthcare ranks #2 out of 118 companies in the Medical Distribution industry, placing it in the top 1.7%.
Is Medistep Healthcare's ROA % too high?
Medistep Healthcare's current ROA % of 21.84% is 44% above median its 10-year median of 15.16. Over the past 10 years, this metric has ranged from a low of 2.67 to a high of 22.47. The Medical Distribution industry median ROA % is 2.22. Medistep Healthcare's value of 21.84% is 886% above this industry median. Based on the distribution chart, Medistep Healthcare ranks #2 out of 118 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Medistep Healthcare has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Medistep Healthcare's ROA % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Medistep Healthcare ranks #2 out of 118 companies for ROA %. This places Medistep Healthcare in the top 2% of its industry — outperforming the majority of peers. The industry median ROA % is 2.22. Medistep Healthcare's value of 21.84% is 886% above this benchmark. Historically, Medistep Healthcare's own ROA % has ranged from 2.67 to 22.47 over the past decade. While the company's 10-year median is 15.16 vs. the industry median of 2.22, Medistep Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Distribution company?
The median ROA % among Medical Distribution companies is 2.22, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medistep Healthcare's current ROA % of 21.84% is 886% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Medistep Healthcare and its competitors. For the Medical Distribution industry, the median ROA % is 2.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medistep Healthcare's current ROA % is 21.84%, which is 44% above median its own 10-year median of 15.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medistep Healthcare stock overvalued right now?
Medistep Healthcare (NSE:MEDISTEP) has a current ROA % of 21.84%. The current ROA % is 21.84%, which is 44% above median its 10-year median of 15.16 and 886% above the Medical Distribution industry median of 2.22. Medistep Healthcare's overall GF Score™ is 19/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Medistep Healthcare (NSE:MEDISTEP), the current ROA % is 21.84% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Medistep Healthcare Ltd operates in the pharmaceutical and healthcare product sectors. Its business includes manufacturing intimate care and hygiene products such as sanitary pads, as well as nutraceutical products like energy powders. The company also trades a variety of pharmaceutical, surgical, and medical equipment products. Medistep Healthcare's operations focus mainly on the western region of India, particularly in Gujarat. Its Core business activity is divided into the following categories: a) Trading of Pharmaceutical & Surgical products, b) Trading & Manufacturing of Nutraceuticals and Intimate care & hygiene products. The company generates the majority of its revenue from Trading and distribution.
19GF Score
Get the complete analysis for NSE:MEDISTEP
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MEDISTEP has been successfully added to your 